http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a8320ec4384cea481334e73f826e043d
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | U. Lin Lin |
| name | Nancy U Lin Nancy U. Lin |
| given-name | Nancy U. Nancy Nancy U |
| organization-name | Nadine Tung, Beth Israel Deaconess Medical Center; Nancy U. Lin, Eric P. Winer, and Judy E. Garber, Dana-Farber Cancer Institute; Nadine Tung, Nancy U. Lin, Eric P. Winer, and Judy E. Garber, Harvard Medical School, Boston, MA; and John Kidd, Brian A. Allen, Nanda Singh, Richard J. Wenstrup, and Anne-Renee Hartman, Myriad Genetic Laboratories, Inc., Salt Lake City, UT. Department of Medical Oncology (N.U.L.), Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215 From the Departments of Medical Oncology and Radiation Oncology, Dana-Farber Cancer Institute; Brigham and Women's Hospital; and Harvard Medical School, Boston, MA Dana-Farber Cancer Institute; Dana-Farber/Brigham and Women’s Cancer Center; Brigham and Women’s Hospital; and Harvard Medical School, Boston, MA Dana‐Farber Cancer Institute Boston Massachusetts USA 1Dana-Farber Cancer Institute, Boston Massachusetts, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: nlin@partners.org. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA Department of Medical Oncology, Dana-Farber Cancer Institute Harvard Medical School , Boston, Massachusetts , USA From M.D. Anderson Cancer Center, Houston (R.K.M., G.H.); Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (S. Loi); the Royal Marsden NHS Foundation Trust, London (A.O.), and Edinburgh Cancer Research Centre, Edinburgh (D.C.) — both in the United Kingdom; Winship Cancer Institute, Atlanta (E.P.); Sarah Cannon Research Institute/Tennessee Oncology–Nashville (E.H.) and Vanderbilt University Medical Center (V.A.), Nashville; University of California, Los Angeles, Medical Center–Jonsson... Dana-Farber Cancer Institute, Boston, Massachusetts, USA Dana-Farber Cancer Institute, Boston, MA, USA. Harvard Medical School, Boston, Massachusetts. Breast Oncology Center, Dana‐Farber Cancer Institute, Harvard Medical School Boston Massachusetts Authors' Affiliations: 1Dana-Farber Cancer Institute, Boston, Massachusetts; 2Medical Oncology Branch, Center for Cancer Research, National Cancer Institute; 3Women's Cancers Section, Laboratory of Molecular Pharmacology; and 4Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA From the Dana-Farber Cancer Institute; Massachusetts General Hospital; Beth Israel Deaconess Medical Center, Boston, MA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC; and the Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC University of Florida Health Cancer Center at Orlando Health, Orlando, FL; American Society of Clinical Oncology, Alexandria, VA; and Dana-Farber Cancer Institute, Boston, MA Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute; Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA; Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN; Carla I. Falkson, University of Alabama, Birmingham, AL; Timothy J. Hobday, Mayo... From the Winship Cancer Institute at Emory University, Atlanta (K.K.); Southwest Oncology Group Statistics and Data Management Center (W.E.B., D.L.L., J.M.) and the University of Washington School of Medicine–Seattle Cancer Care Alliance (J.R.G.) — both in Seattle; the University of Texas M.D. Anderson Cancer Center, Houston (F.M.-B., D.T., G.N.H.); Loyola University Chicago, Maywood, IL (K.S.A.); the University of Michigan, Ann Arbor (D.F.H., A.F.S.); Dana–Farber Cancer Institute, Boston (N.U.L.); Mayo... Department of Medical Oncology, Dana-Farber/Brigham and Women's Cancer Center, 450 Brookline Avenue, Boston, MA 02215, USA. nlin@partners.org Naren Ramakrishna, University of Florida Health Cancer Center at Orlando Health, Orlando; Edith A. Perez, Mayo Clinic, Jacksonville; Jennifer Levinson, Ponte Vedra Beach, FL; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Sarat Chandarlapaty and Shanu Modi, Memorial Sloan Kettering Cancer Center; Francisco J. Esteva, New York University Cancer Institute, New York; Jeffrey J. Kirshner, Hematology/Oncology Associates of Central New York, East Syracuse, NY; Jennie R. Crews, PeaceHealth... Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts Kala Visvanathan, Johns Hopkins University School of Medicine and Bloomberg School of Public Health; MaryJo S. Fackler, Zhe Zhang, Zoila A. Lopez-Bujanda, Stacie C. Jeter, Lori J. Sokoll, Leslie M. Cope, Christopher B. Umbricht, David M. Euhus, Saraswati Sukumar, and Antonio C. Wolff, Johns Hopkins University School of Medicine, Baltimore, MD; Elizabeth Garrett-Mayer, Medical University of South Carolina, Charleston, SC; Andres Forero, University of Alabama at Birmingham, Birmingham, AL; Anna M.... Ines Vaz-Luis, Melissa E. Hughes, Harold J. Burstein, Jane C. Weeks, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital, Boston, MA; Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal; Rebecca A. Ottesen and Rizvan Mamet, City of Hope, Duarte; Hope S. Rugo, University of California, San Francisco, San Francisco, CA; Stephen B. Edge, Roswell Park Cancer Institute, Buffalo, NY; Stephen B. Edge, Baptist Cancer Center, Memphis, TN; and Ana... 8Department of Oncologic Pathology, Harvard Medical School, Massachusetts.; 9Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. Naren Ramakrishna, University of Florida Health Cancer Center at Orlando Health, Orlando; Jennifer Levinson, Ponte Vedra Beach, FL; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Sarat Chandarlapaty and Shanu Modi, Memorial Sloan Kettering Cancer Center; Francisco J. Esteva, New York University Langone Medical Center, New York; Jeffrey J. Kirshner, Hematology/Oncology Associates of Central New York, East Syracuse, NY; Jennie R. Crews, Seattle Cancer Care Alliance, Seattle, WA; Nancy... Dana-Farber Cancer Institute, Boston, Massachusetts, USA; 1Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. From the Harvard Radiation Oncology Program; Massachusetts General Hospital; and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Department of Medical Oncology, Dana-Farber Cancer Institute , Boston, MA , USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center , Boston, MA , USA; Harvard Medical School , Boston, MA , USA Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA Department of Medical Oncology, Dana-Farber Cancer Institute, and Harvard Medical School , Boston, MA , USA Breast Oncology Program, Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115; Rachel A. Freedman, Rebecca S. Gelman, Christina Herold, Nicole Ryabin, Sarah Farooq, Elizabeth Lawler, Ian E. Krop, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital; Alarice Lowe and Nathalie Y.R. Agar, Brigham and Women’s Hospital, Boston, MA; Jeffrey S. Wefel, Kenneth R. Hess, and Nuhad Ibrahim, The University of Texas MD Anderson Cancer Center; Polly A. Niravath and Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; Michelle E.... Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts Dana-Farber Cancer Institute, Harvard Medical School , Boston, Massachusetts , USA Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA Dana-Farber Cancer Institute, Boston, MA Department of Medical Oncology, Dana-Farber Cancer Institute , Boston, MA, USA Dana-Farber/Brigham & Women's Cancer Center, Boston, MA Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts, USA Daniel G. Stover, Ohio State University Comprehensive Cancer Center, Columbus, OH; Heather A. Parsons, Gavin Ha, William T. Barry, Hao Guo, Atish D. Choudhury, Melissa E. Hughes, Deborah A. Dillon, Ann H. Partridge, Nikhil Wagle, Ian E. Krop, Todd R. Golub, Eric P. Winer, Sara M. Tolaney, and Nancy U. Lin, Dana-Farber Cancer Institute; Gad Getz, Massachusetts General Hospital, Boston; Gavin Ha, Samuel S. Freeman, Atish D. Choudhury, Gregory Gydush, Sarah C. Reed, Justin Rhoades, Denisse Rotem, Nikhil... Breast Oncology, Dana Farber Cancer Institute , Boston, MA , US Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts Edward S. Kim, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC; Suanna S. Bruinooge, Caroline Schenkel, and Richard L. Schilsky, ASCO, Alexandria, VA; Samantha Roberts, Marina Kozak, Jeff Allen, and Ellen Sigal, Friends of Cancer Research; Samantha Roberts, Genentech, Washington, DC; Gwynn Ison, Julia A. Beaver, Rajeshwari Sridhara, and Tatiana M. Prowell, US Food and Drug Administration, Silver Spring; Thomas S. Uldrick and Andrea M. Denicoff, National Cancer Institute, Bethesda, MD;... Dana-Farber Cancer Institute, Boston, Massachusetts. Dana-Farber Cancer Institute; and Boston University School of Medicine, Boston, MA Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts Department of Medical Oncology, Dana–Farber Cancer Institute, Boston, MA 02215; Department of Medical Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts , USA From the Dana-Farber Cancer Institute, Brigham & Women's Hospital, and Harvard Medical School, Boston, Massachusetts. Ines Vaz-Luis, Nancy U. Lin, Eric P. Winer, and Rachel A. Freedman, Dana-Farber Cancer Institute; Nancy L. Keating, Harvard Medical School; Nancy L. Keating and Huichuan Lii, Brigham and Women's Hospital, Boston, MA; and Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal. Nancy U. Lin, Dana-Farber Cancer Institute, Boston; Oliver Rosen, Deciphera Pharmaceuticals, Waltham, MA; Tatiana Prowell, Laleh Amiri-Kordestani, and Joohee Sul, US Food and Drug Administration, Silver Spring; Tatiana Prowell, Johns Hopkins Kimmel Cancer Center, Baltimore, MD; Antoinette R. Tan and Edward S. Kim, Carolinas HealthCare System, Charlotte, NC; Marina Kozak, Friends of Cancer Research; Louise Perkins, Melanoma Research Alliance, Washington, DC; Julia White, The Ohio State University,... Dana-Farber Cancer Institute, Boston, MA; and Marin Cancer Care, Greenbrae, CA Departments of Medical Oncology, Boston, Massachusetts, USA Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA Sharon H. Giordano, The University of Texas MD Anderson, Houston; Debra A. Patt, Texas Oncology, Austin, TX; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Sarat Chandarlapaty and Shanu Modi, Memorial Sloan Kettering Cancer Center; Francisco J. Esteva, New York University Langone Medical Center, New York; Jeffrey J. Kirshner, Hematology/Oncology Associates of Central New York, East Syracuse, NY; Jennie R. Crews, Seattle Cancer Care Alliance; Nancy E. Davidson, Fred Hutchinson Cancer... Breast Oncology Program, Dana-Farber Cancer Institute , Boston, Massachusetts , USA Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215; Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115; Department of Medicine, Harvard Medical School, Boston, MA 02115 Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; 2Department of Medicine, Harvard Medical School, Boston, Massachusetts. From the Harvard Radiation Oncology Program; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital; Department of Medical Oncology, Dana-Farber Cancer Institute; Department of Surgery, Brigham and Women's Hospital, Boston, MA Dana‐Farber Cancer Institute Boston MA USA; Harvard Medical School Boston MA USA Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, MA Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Author's Affiliation: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts From the Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts Division of Breast Oncology, Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. nlin@partners.org 7Dana-Farber Cancer Institute, and Dana-Farber Cancer Institute, Boston, Massachusetts Department of Medical Oncology Dana‐Farber/Harvard Cancer Center 450 Brookline Avenue Boston MA 02215 USA From the Breast Oncology Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO; Department of Neuro-Oncology, University of Turin and City of Health and Science Hospital, Turin, Italy. Susan F. Smith Center for Women’s Cancers, Inflammatory Breast Cancer Program, Dana-Farber Cancer Institute, Boston, MA, USA |
Incoming Links
Total number of triples: 312.